Oral Health Sciences Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Acta Odontol Scand. 2021 Aug;79(6):402-417. doi: 10.1080/00016357.2020.1869827. Epub 2021 Jan 16.
To compare the remineralization potential and caries preventive efficacy of CPP-ACP/bioactive glass/xylitol/ozone and topical fluoride (TF) combined therapy versus TF mono-therapy.
Embase, PubMed, Scopus, Web of Science and Cochrane databases were searched. 4457 records were screened and 26 trials were included. Data from 16 trials was pooled using Review Manager 5.4. Level of significance was < .05. The certainty of the evidence was evaluated using GRADE.
Pooled analysis of two trials for white spot lesions (WSLs) regression (SMD -0.6, 95% CI: [-1.07 to -0.14], = .01) and three trials for post-intervention DIAGNOdent values (SMD -1.24, 95% CI: [-1.96 to -0.52], = .0007) significantly favoured CPP-ACP-TF combined therapy over TF mono-therapy. The sub-group analysis for caries increment (SMD -0.14, 95% CI: [-0.21 to -0.07], < .0001) and the post intervention count (SMD -0.42, 95% CI: [-0.62 to -0.23], < .0001) significantly favours 'xylitol-TF' and 'CPP-ACP-TF' combined therapy respectively. The high/unclear risk of bias, imprecision and indirectness of the included trials presented a low certainty of evidence.
CPP-ACP-TF exhibits superiority over TF monotherapy in remineralizing existing lesions and demonstrates better antibacterial effect, whereas it is not more effective for preventing caries incidence. However, Xylitol exerts an added benefit over fluoride alone in preventing caries increment. The low-certainty evidence highlights the need for more good quality trials.
比较 CPP-ACP/生物活性玻璃/木糖醇/臭氧与局部用氟化物(TF)联合治疗与 TF 单一疗法在再矿化潜力和防龋效果方面的差异。
检索了 Embase、PubMed、Scopus、Web of Science 和 Cochrane 数据库。筛选了 4457 条记录,纳入了 26 项试验。使用 Review Manager 5.4 对 16 项试验的数据进行了汇总。显著性水平为 < .05。使用 GRADE 评估证据的确定性。
两项试验的汇总分析显示,对于白斑病变(WSL)的消退(SMD -0.6,95%CI:[-1.07 至 -0.14], = .01)和三项试验的干预后 DIAGNOdent 值(SMD -1.24,95%CI:[-1.96 至 -0.52], = .0007),CPP-ACP-TF 联合治疗明显优于 TF 单一治疗。对于龋增量(SMD -0.14,95%CI:[-0.21 至 -0.07], < .0001)和干预后计数(SMD -0.42,95%CI:[-0.62 至 -0.23], < .0001)的亚组分析分别表明,“木糖醇-TF”和“CPP-ACP-TF”联合治疗具有显著优势。纳入试验的高/不确定偏倚风险、不精确性和间接性导致证据的确定性较低。
CPP-ACP-TF 在再矿化现有病变方面优于 TF 单一治疗,并且具有更好的抗菌效果,而在预防龋齿发生率方面效果并不更好。然而,木糖醇在预防龋齿增量方面比单独使用氟化物具有额外的益处。低确定性证据强调了需要更多高质量的试验。